Does Intra-Uterine Exposure to the Zika Virus Increase Risks of Cognitive Delay at Preschool Ages? Findings from a Zika-Exposed Cohort from Grenada, West Indies
Authors:
- Michelle FernandesMFMichelle Fernandes
- Roberta EvansRERoberta Evans
- Mira ChengMCMira Cheng
- Barbara LandonBLBarbara Landon
- Trevor NoëlTNTrevor Noël
- Calum MacphersonCMCalum Macpherson
- Nikita CudjoeNCNikita Cudjoe
- Kemi S. BurgenKBKemi S. Burgen
- Randall WaechterRWRandall Waechter
- A. Desiree LaBeaudALA. Desiree LaBeaud
- Karen BlackmonKBKaren Blackmon
Open Access
Abstract
Maternal infection with Zika virus (ZIKV) is associated with a distinct pattern of birth defects, known as congenital Zika syndrome (CZS). In ZIKV-exposed children without CZS, it is often unclear whether they were protected from in utero infection and neurotropism. Early neurodevelopmental assessment is essential for detecting neurodevelopmental delays (NDDs) and prioritizing at-risk children for early intervention. We compared neurodevelopmental outcomes between ZIKV-exposed and unexposed children at 1, 3 and 4 years to assess exposure-associated NDD risk. A total of 384 mother–child dyads were enrolled during a period of active ZIKV transmission (2016–2017) in Grenada, West Indies. Exposure status was based on laboratory assessment of prenatal and postnatal maternal serum. Neurodevelopment was assessed using the Oxford Neurodevelopment Assessment, the NEPSY® Second Edition and Cardiff Vision Tests, at 12 (n = 66), 36 (n = 58) and 48 (n = 59) months, respectively. There were no differences in NDD rates or vision scores between ZIKV-exposed and unexposed children. Rates of microcephaly at birth (0.88% vs. 0.83%, p = 0.81), and childhood stunting and wasting did not differ between groups. Our results show that Grenadian ZIKV-exposed children, the majority of whom were without microcephaly, had similar neurodevelopmental outcomes to unexposed controls up to at least an age of 4 years.Keywords
Funding Information
- St. George’s University (GSP-SRGI-18009, AID-OAA-A-14-00028, R21HD093551-01)
- United States Agency for International Development (GSP-SRGI-18009, AID-OAA-A-14-00028, R21HD093551-01)
- National Institutes of Health (GSP-SRGI-18009, AID-OAA-A-14-00028, R21HD093551-01)
- Stanford Maternal Child Health Research Institute New Ideas Award (ADL) (GSP-SRGI-18009, AID-OAA-A-14-00028, R21HD093551-01)
- Medical Research Council (GSP-SRGI-18009, AID-OAA-A-14-00028, R21HD093551-01)
This publication has 39 references indexed in Scilit:
- Type III Interferons Produced by Human Placental Trophoblasts Confer Protection against Zika Virus InfectionCell Host & Microbe, 2016
- NEPSY-II: A Developmental Neuropsychological Assessment, Second EditionChild Neuropsychology, 2009
- WHO Child Growth Standards based on length/height, weight and age.2006
- WHO Child Growth Standards based on length/height, weight and ageActa Paediatrica, 2006
- Members of the who Multicentre Growth Reference Study GroupFood and Nutrition Bulletin, 2004
- The who Multicentre Growth Reference Study: Planning, Study Design, and MethodologyFood and Nutrition Bulletin, 2004
- The Cardiff acuity test used for measuring visual acuity development in toddlersVision Research, 1994
- The Cardiff Test: A New Visual Acuity Test for Toddlers and Children with Intellectual Impairment. A Preliminary ReportOptometry and Vision Science, 1992
- The GHQ-12 as a screening tool in a primary care settingSocial Psychiatry and Psychiatric Epidemiology, 1990
- Home environment questionnaireJournal of Abnormal Child Psychology, 1984